Skip to content
ContentLora

    Tip: press / anywhere to search.

    organization

    BioMADE

    Also known as Bioindustrial Manufacturing and Design Ecosystem

    BioMADE is a Manufacturing USA institute that builds national infrastructure for taking biotechnology from the laboratory to commercial production.[1] Its first demonstration facility, a $132 million site in Maple Grove, Minnesota with two 25,000-litre fermenters, was finalised in April 2025, with pilot sites in Hayward, California and near Ames, Iowa following.[2][3][4]

    Editor reviewedUpdated Synthetic biologyTech policyScience
    Key facts

    What it is

    BioMADE is a Manufacturing USA institute focused on bioindustrial manufacturing. Its stated purpose is to establish national infrastructure for scaling biotechnology from laboratory development to commercial production, which in practice means shared fermentation plants that no single startup could finance alone.[1] Funding comes chiefly from the US Department of Defense, which provided about $87 million at the institute’s inception and directed a further $450 million in 2023.[5]

    The capacity argument

    The institute frames the problem as a missing rung on the ladder between bench and factory. It says the shortage of pilot- to demonstration-scale capacity forces American companies to seek facilities overseas, taking American innovation with them and risking loss of intellectual property.[6] Its chief executive has said the United States has led biotechnology research for more than 40 years but needs additional assets to bring innovations from the laboratory to commercial production.[7] Independent reporting agrees on the diagnosis, describing the country as severely short of pilot- and demonstration-scale precision fermentation equipment.[8]

    The sites

    The anchor project is in Maple Grove, Minnesota: a $132 million investment finalised on 29 April 2025, funded by the Department of Defense and Minnesota’s economic development department, covering 122,000 square feet with two 25,000-litre industrial fermenters for demonstration-scale piloting.[2]

    The wider Pilot Plant Network has three sites. Hayward, California is a nearly 25,000-square-foot multi-user plant with aerated stirred tanks of up to 4,000 litres, in a project worth at least $80 million funded by the Department of Defense; BioMADE said in April 2025 that it aimed to open it to customers in early 2026.[3] The Iowa site near Ames, operated with Iowa State University, is 15,000 square feet with 5,000 and 10,000-litre fermenters, in a $40 million project to which BioMADE committed at least $20 million, matched by up to $10 million from the university and $10 million from a state infrastructure programme.[4] Published schedules have shifted, so dates are plans rather than commitments: BioMADE said in August 2025 that Iowa would open in early 2028, and at the November 2025 groundbreaking that it was scheduled to open in 2027.[9] BioMADE describes the network as critically needed pilot-scale capacity to move products out of the laboratory and into commercial and defence markets.[10]

    Context

    BioMADE’s build-out matches the direction of federal policy advice. A congressionally created commission delivered 49 recommendations in April 2025 and called for at least $15 billion of US investment in biotechnology innovation and biomanufacturing.[11][12] Research funding moved in the same period: in April 2026 the Department of Defense and the National Science Foundation directed $21.4 million to 14 bioengineering research projects.[13]

    Government demand also shows up on company income statements. Government and defence customers accounted for 45% of Ginkgo Bioworks’ revenue in the second quarter of 2026 and 41% in the first half, its largest customer group.[14]

    What is unresolved

    Whether shared plants fix the gap depends on utilisation. BioMADE publishes each site’s size, cost and target opening date, but capacity bookings, tech-transfer times and cost per run are not in its releases.[3][4] The debate over whether public tankage or private capital should close the scale-up gap is covered in the precision fermentation page and in this field’s scale-up analysis.[8]

    Questions readers ask

    What does BioMADE do?

    It is a Manufacturing USA institute for bioindustrial manufacturing that works to build national infrastructure for taking biotechnology from the lab to commercial production.[1]

    How big are its fermenters?

    Its Minnesota demonstration facility has two 25,000-litre industrial fermenters; the Hayward pilot site uses 4,000-litre tanks and the Iowa site 10,000-litre tanks.[2][3][4]

    Who pays for it?

    Chiefly the US Department of Defense, which provided about $87 million at inception and directed a further $450 million in 2023; Minnesota's economic development department co-funded the Maple Grove site.[5][2]

    Why does the United States want its own pilot plants?

    BioMADE says the shortage of pilot- to demonstration-scale capacity pushes American companies to facilities overseas, taking innovation with them and risking loss of intellectual property.[6]

    Sources

    Each numbered claim is a statement we checked against the sources listed with it. Status shows how well established it is.

    1. [1]

      BioMADE is a Manufacturing USA institute for bioindustrial manufacturing that works to build national infrastructure for taking biotechnology from laboratory scale to commercial production. confirmedas of 2025-04-29

    2. [2]

      On 29 April 2025 BioMADE finalised a $132 million investment, funded by the US Department of Defense and Minnesota's economic development department, in a 122,000-square-foot demonstration-scale biomanufacturing facility in Maple Grove, Minnesota with two 25,000-litre industrial fermenters. confirmedas of 2025-04-29

    3. [3]

      BioMADE's California pilot plant in Hayward is a nearly 25,000-square-foot multi-user facility with aerated stirred tanks of up to 4,000 litres, in a project worth at least $80 million funded by the US Department of Defense; BioMADE said in April 2025 that it aimed to open it to customers in early 2026. confirmedas of 2025-04-30

    4. [4]

      BioMADE's Iowa pilot plant, built near Ames with Iowa State University, is a 15,000-square-foot multi-user site with 5,000 and 10,000-litre industrial fermenters, in a $40 million project to which BioMADE committed at least $20 million, matched by up to $10 million from the university and $10 million from a state infrastructure programme. confirmedas of 2025-11-14

    5. [5]

      The US Department of Defense gave BioMADE about $87 million at its inception and directed a further $450 million to it in 2023. reportedas of 2026-05-11

    6. [6]

      BioMADE says the shortage of pilot- to demonstration-scale capacity forces American companies to use facilities overseas, taking innovation with them and risking loss of intellectual property. confirmedas of 2025-04-29

    7. [7]

      BioMADE's chief executive said the United States has led biotechnology research for more than 40 years but needs additional assets to bring innovations from the laboratory to commercial production. confirmedas of 2025-04-29

    8. [8]

      The United States is reported to be severely short of pilot- and demonstration-scale equipment for precision fermentation, which is the stated reason for federal investment in bioindustrial pilot plants. reportedas of 2026-05-11

    9. [9]

      BioMADE's stated opening date for the Iowa pilot plant has moved. An August 2025 release said the site was set to open in early 2028, while the November 2025 groundbreaking release said it was scheduled to open in 2027. disputedas of 2025-11-14

    10. [10]

      BioMADE describes its Pilot Plant Network as critically needed pilot-scale bioindustrial manufacturing facilities intended to move products out of the laboratory and into commercial and defence markets. confirmedas of 2026-04-29

    11. [11]

      The National Security Commission on Emerging Biotechnology, a bipartisan body created by the fiscal 2022 National Defense Authorization Act, delivered its final report "Charting the Future of Biotechnology" to Congress in April 2025 with 49 recommendations. confirmedas of 2025-04-30

    12. [12]

      The commission's headline recommendation is at least $15 billion of US government investment to grow biotechnology innovation and biomanufacturing. confirmedas of 2025-04-30

    13. [13]

      In April 2026 the US Department of Defense and the National Science Foundation directed $21.4 million to 14 bioengineering research projects. reportedas of 2026-05-11

    14. [14]

      Government and defence customers accounted for 45% of Ginkgo Bioworks' revenue in the second quarter of 2026 and 41% in the first half, its largest customer group. confirmedas of 2026-06-30

    15. [15]

      BioMADE said in November 2025 that its network had passed 325 members across 40 states, and that it was catalysed by the US Department of Defense in October 2020 as a member of Manufacturing USA. confirmedas of 2025-11-14

    Revision history (2)
    1. Page created.
    2. Refresh: re-sourced the pilot plant network to BioMADE's own releases (Hayward, Iowa), recorded the Iowa opening-date conflict (2027 against early 2028), and added the network size and the April 2026 project awards.

    Created Oct 10, 2026. Last reviewed by an editor on Oct 10, 2026. Next scheduled review: Jan 10, 2027.

    Cite this page

    "BioMADE." ContentLora, updated Oct 10, 2026. https://contentlora.com/wiki/biomade

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.

    Keep exploring

    Connections
    Precision fermentat… Builds capacity forGinkgo Bioworks Serves customers such as
    ☰ Contents